Neurolytic celiac plexus block: A better alternative to opioid treatment in upper abdominal malignancies: An Indian experience

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 19, Issue 3, 2005, Pages 15-20

  Jain, P N ^a   Shrikhande, S V ^a   Myatra, Sheila N ^a   Sareen, R ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Cancer pain; Neurolytic celiac plexus block; Opioid consumption; Quality of life

Indexed keywords

MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

ABDOMINAL CANCER; ADULT; ANALGESIA; ANOREXIA; ARTICLE; BACKACHE; CANCER PAIN; CELIAC PLEXUS; CONSTIPATION; CONTROLLED STUDY; DEVELOPING COUNTRY; DIARRHEA; FEMALE; HEALTH CARE ACCESS; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; NERVE BLOCK; NEUROLYSIS; PROGNOSIS; QUALITY OF LIFE; TREATMENT OUTCOME;

ADULT; AGED; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELIAC PLEXUS; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; HUMANS; INDIA; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; MORPHINE; NERVE BLOCK; PAIN, INTRACTABLE; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 27944499753     PISSN: 15360288     EISSN: None     Source Type: Journal    
DOI: 10.1300/J354v19n03_04     Document Type: Article

References (14)

1. Polati E, Finco G, Gottin C, Bassi C, Pederzoli P, Ischia S. A prospective randomized double blind trial of neurolytic celiac plexus block in patients with pancreatic cancer. Br J Surg 1998; 85:199-201.
2. Rajagopal MR, Joranson DE, Gilson AM. Medical use, misuse, and diversion of opioids in India. Lancet 2001; 358 (9276):139-143.
3. Joranson DE, Rajagopal MR, Gilson AM. Improving access to opioid analgesics for palliative care in India. J Pain Symptom Manage 2002; 24:152-159.
4. International Narcotics Control Board. "Demographic Yearbook", 1999:New York, NY.
5. Kaiser MH, Barkin J, MacIntyre JM. For trie gastro-intestinal tumour study group, pancreatic cancer: assessment of prognosis by clinical presentation. Cancer. 1985; 56:397-402.
6. Hermann RE, Cooperman AM. Current concepts in cancer: cancer of pancreas. New Engl J Med 1979; 301:482-485.
7. Levy M. Pain management in advanced cancer. Sem Oncol 1985; 12:394-410.
8. Ahles TA, Blanchard EB, Ruckdeschel JC. The multidimensional nature of cancer related pain. Pain 1983; 17:277-288.
9. Ischia S, Ischia A, Polati E, Finco G. Three posterior percutaneous celiac plexus block techniques: a prospective randomized study in 61 patients with pancreatic cancer pain. Anesthesiology 1992; 76:534-540.
10. Lillemoe KD, Cameron JC, Kaufman HS, Yeo CJ, Pitt HA, Sanier PK. Chemical splachnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg 1993; 217:447-457.
11. Mercandante S. Celiac plexus block versus analgesics in pancreatic cancer pain. Pain 1993;52:187-192.
12. Kawamata M, Ishitani K, Ishikawa K, Sasaki H, Ota K, Omote K et al. Comparison between celiac plexus block and morphine treatment on quality of life in patients with pancreatic cancer pain. Pain 1996; 64:597-602.
13. Wong GY, Schroeder DR, Cams PE, Wilson JL, et al. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer. JAMA 2004; 291:1092-1099.
14. Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain. A meta-analysis. Anesth Analg 1995; 80:290-295.